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Introduction. The Angelchik prosthesis (AP) is a historic antireﬂux device which consists of a C-shaped silicone ring placed around
the gastroesophageal junction (GEJ) and secured by Dacron tape. We present a rare experience with an AP and its impact on
bariatric surgical outcomes. Case. Our patient is a 66-year-old woman who had an open antireﬂux procedure with an AP in
1987. She presented to a bariatric clinic for consideration of bariatric surgery for the treatment of morbid obesity and associated
comorbidities. She also reported signiﬁcant problems with reﬂux and dysphagia. After an appropriate work-up, an AP was
identiﬁed at her GEJ. She was taken to the operating room for laparoscopic removal with planned interval laparoscopic sleeve
gastrectomy. Intraoperatively, the AP was identiﬁed around the GEJ; after extensive adhesiolysis, the prosthesis was removed.
Postoperatively, in order to determine if the AP had caused any lasting esophageal motility problems, the patient underwent a
high-resolution esophageal manometry which demonstrated normal esophageal motility. Interval laparoscopic sleeve
gastrectomy was performed safely 9 weeks later. Conclusion. Although rarely used, it is still possible to encounter an Angelchik
prosthesis in practice. General and bariatric surgeons need to be aware of this rare device and understand how to manage its
related complications.

1. Introduction
The Angelchik prosthesis (AP) was ﬁrst introduced in 1979
as an antireﬂux device and initially became popular due to
its simple design and ease of insertion [1–3]. It is a Cshaped silicon ring that is ﬁtted around the gastroesophageal
junction (GEJ) and secured in place by a Dacron ribbon [2].
However, it is a device rarely seen today due to widespread
reports of complications such as migration, displacement,
erosion, and dysphasia [1, 2]. Displacement may be directed
upward into the mediastinum through a wide hiatus, downward onto the body of the stomach, or by a 180-degree rotation pinching the esophagus. The most common of these
complications was dysphagia (reported rates of 70% up to
96%), followed by device migration and device erosion. [1,
2] Incidence of postoperative dysphagia increased over time,
with initial results showing signiﬁcant rates of dysphagia
(37% to 43% at 1 year), with rates only increasing with longer
follow up [4–6]. Dysphagia was noted to be directly caused

by the prosthesis, demonstrated by greatly delayed esophageal emptying times [7]. Removal was required most frequently due to dysphagia or reﬂux, and the rate of a second
operation was 10% or greater, a rate much higher than other
antireﬂux operations [7–9]. Due to these results, the device
became obsolete as a routine option for the treatment of gastroesophageal reﬂux disease. However, it is estimated that
more than 30,000 Angelchik devices were implanted worldwide prior to this, and thus it is still possible to encounter
these devices in current surgical practice [10].

2. Case Summary
Our patient is a 66-year-old woman referred to a bariatric
clinic for consideration of bariatric surgery for long-term
morbid obesity with BMI of 44 and associated comorbidities
including diabetes, sleep apnea, and GERD. She had a surgical history of an open antireﬂux procedure with an Angelchik
prosthesis in 1987. She reported signiﬁcant problems with
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(a) Angelchik prosthesis (AP) in situ

(b) AP Dacron ribbon encircling the GEJ

(c) AP dissected free

(d) AP ex vivo

(e) Laparoscopic sleeve gastrectomy

(f) UGI after sleeve gastrectomy

Figure 1: (a–f) Laparoscopic removal of Angelchik prosthesis and interval sleeve gastrectomy. (a) Angelchik prosthesis (AP) in situ. (b) AP
Dacron ribbon seen encircling the gastroesophageal junction (GEJ). (c) AP dissected free. (d) Angelchik prosthesis ex vivo. (e) Laparoscopic
sleeve gastrectomy. (f) UGI after laparoscopic sleeve gastrectomy.

daily reﬂux and progressive dysphagia to solids and some liquids. Her initial work-up included an upper GI study, an esophagogastroduodenoscopy (EGD), and a CT scan. The upper
GI study and CT scan showed the AP in place at the GEJ. On
retroﬂexion during the EGD, the indentation of a band of
foreign body was present at the GEJ without evidence of
erosion.
She underwent elective laparoscopic removal of the AP,
with plan for interval laparoscopic sleeve gastrectomy. During the operation to remove the AP, dense adhesions were
encountered between the site of the device, the fundus of
the stomach, diaphragm, and the left lobe of the liver.
After performing extensive adhesiolysis, the AP was visualized and removed (Figures 1(a)–1(d)). Postoperatively, her
dysphagia and reﬂux was resolved. In order to determine if
the AP had caused any lasting esophageal motility problems,
she underwent a high-resolution esophageal manometry
which demonstrated normal motility.
After this work-up and recovery, laparoscopic sleeve gastrectomy was safely performed nine weeks later (Figure 1(e)).
Due to signiﬁcant adhesive disease, the left crus was not well
visualized. At her 3-month follow-up visit, the patient had
lost 9 lbs since surgery (10% EWL) and she continued to
remain free of dysphagia or reﬂux symptoms. An upper GI
series demonstrated retained fundus, which may explain
the inadequate weight loss (Figure 1(f)).

3. Discussion
Although the Angelchik prostheses are no longer being used,
it is still possible to encounter one in practice secondary to
the myriad of complications associated with them. General
and bariatric surgeons should be aware of this rare device
and understand how to manage its related complications.
Stewart et al. in 1994 described their outcomes after removal
of the device secondary to dysphagia, recurrent reﬂux, and
migration [11]. They noted frequent intraoperative diﬃculty
with removal due to a dense ﬁbrous capsule [11]. Another
case report of laparoscopic removal of the Angelchik prosthesis due to complaints of dysphagia also noted dense adhesions to the proximal stomach, diaphragm, and liver with an
extensive ﬁbrous pseudocapsule enclosing the ring. An UGI
postoperatively showed no evidence of contrast extravasation
and the patient was discharged in 2 days with resolution of
dysphagia [10].
It has also been observed that if reﬂux was a dominant
complaint prior to Angelchik prosthesis placement, reﬂux
was commonly noted to recur after the removal of the device
[11]. It was suggested by Stewart et al. that an alternative
antireﬂux procedure be performed in these cases [11]. Our
patient’s dysphagia and reﬂux was resolved after removal,
and interval high-resolution manometry revealed normal
esophageal motility. Thus, laparoscopic sleeve gastrectomy
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was performed in order to address the patient’s remaining
issue of severe morbid obesity and associated comorbidities.
Laparoscopic sleeve gastrectomy is eﬀective in producing
weight loss and improving diabetes; however, evidence of
the eﬀect on GERD postoperatively has been inconsistent
[12, 13]. Therefore for patients with persistent reﬂux preoperatively after removal of an Angelchik device, it may be prudent to discuss alternative antireﬂux options at the time of
surgery. In addition, in patients similar to ours with concomitant morbid obesity, a Roux-en-Y gastric bypass as an alternative to sleeve gastrectomy can more eﬀectively address the
reﬂux symptoms. Although there is no literature available to
support whether to perform laparoscopic sleeve gastrectomy
or laparoscopic Roux-en-Y gastric bypass in patients who
undergo removal of an Angelchik prosthesis, an AP is a foreign body around the GEJ with similar characteristics to a
laparoscopic gastric band. Data suggest that conversion from
a gastric band to either laparoscopic sleeve gastrectomy or
laparoscopic Roux-en-Y gastric bypass is safe and eﬃcacious
when performed in a single-stage or a delayed fashion. The
decision to convert this patient to a sleeve gastrectomy
instead of a gastric bypass was made for several reasons: ﬁrst,
the patient did not have ongoing dysphagia or reﬂux symptoms and had normal esophageal motility following AP
removal; second, she had signiﬁcant intraabdominal adhesive
disease; and third, she had chronic lower extremity pain with
possible ongoing need for nonsteroidal anti-inﬂammatory
medications (NSAIDs). In order to be a safe candidate for
gastric bypass, patients must commit to being NSAID-free
lifelong, as the use of NSAIDs following gastric bypass can
lead to marginal ulcer formation. For patients who have an
AP removed but continue to have signiﬁcant reﬂux or dysphagia symptoms and morbid obesity, conversion to a gastric
bypass is the optimal approach to address both conditions.
Our case, as well as the previous literature, suggests
that it is important to be aware of the pathophysiology
of the Angelchik prosthesis, as patients may present with
associated complications. There is relative diﬃculty with
removal described in various case reports. Laparoscopic
removal should therefore be performed by surgeons familiar with the esophageal hiatus. Intervention should be considered highly in patients presenting with any of the
common symptoms, particularly dysphagia and reﬂux, as
resolution of these is noted in the majority of case reports
describing removal.
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Supplementary Materials
The attached case video demonstrates the case of a 66-yearold woman with a history of morbid obesity who presented
to a bariatric surgery clinic with the complaint of dysphagia.
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Further work-up noted an Angelchik prosthesis at her gastroesophageal junction. She underwent staged removal of
the prosthesis with resolution of her dysphagia and subsequent laparoscopic sleeve gastrectomy. (Supplementary
Materials)
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